Health Care [ 7/12 ] | Health Care Equipment & Supplies [ 38/74 ]
NYSE | Common Stock
Stryker Corporation operates as a medical technology company.
It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.
The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products.
The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies.
The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries.
Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jan 28, 25 | 4.01 Increased by +15.90% | 3.87 Increased by +3.62% |
| Oct 29, 24 | 2.87 Increased by +16.67% | 2.77 Increased by +3.61% |
| Jul 30, 24 | 2.81 Increased by +10.63% | 2.79 Increased by +0.72% |
| Apr 30, 24 | 2.50 Increased by +16.82% | 2.35 Increased by +6.38% |
| Jan 30, 24 | 3.46 Increased by +15.33% | 3.27 Increased by +5.81% |
| Nov 2, 23 | 2.46 Increased by +16.04% | 2.43 Increased by +1.23% |
| Aug 3, 23 | 2.54 Increased by +12.89% | 2.38 Increased by +6.72% |
| May 1, 23 | 2.14 Increased by +8.63% | 2.00 Increased by +7.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 6.44 B Increased by +10.68% | 546.00 M Decreased by -52.23% | Increased by +8.48% Decreased by -56.84% |
| Sep 30, 24 | 5.49 B Increased by +11.92% | 834.00 M Increased by +20.52% | Increased by +15.18% Increased by +7.69% |
| Jun 30, 24 | 5.42 B Increased by +8.53% | 825.00 M Increased by +11.79% | Increased by +15.22% Increased by +3.01% |
| Mar 31, 24 | 5.24 B Increased by +9.73% | 788.00 M Increased by +33.11% | Increased by +15.03% Increased by +21.30% |
| Dec 31, 23 | 5.82 B Increased by +11.78% | 1.14 B Increased by +103.02% | Increased by +19.66% Increased by +81.62% |
| Sep 30, 23 | 4.91 B Increased by +9.60% | 692.00 M Decreased by -15.20% | Increased by +14.10% Decreased by -22.62% |
| Jun 30, 23 | 5.00 B Increased by +11.20% | 738.00 M Increased by +12.50% | Increased by +14.77% Increased by +1.17% |
| Mar 31, 23 | 4.78 B Increased by +11.77% | 592.00 M Increased by +83.28% | Increased by +12.39% Increased by +63.99% |